surmount tirzepatide trials for Obesity Treatment and Diabetes Prevention Surmount Press Briefing #ADA2022

Persistent color changes warrant attention

The Weight Regain Question This is one of the hardest conversations in obesity medicine, and it's one that should happen before starting therapy, not after

Plant Physiol 102:803810 Jeppesen MG, Ortiz P, Shepard W, Kinzy TG, Nyborg J, Andersen GR (2003) The crystal structure of the glutathione S -transferase-like domain of elongation factor 1B gamma from Saccharomyces cerevisiae

Documentation for building strong cases encompasses the following elements: Prescription history showing Ozempic dosage, duration, and prescribing indication (diabetes versus weight loss) Emergency department records detailing acute symptom presentation and treatment Hospitalization records demonstrating severity through admission duration, IV hydration, nutritional support Diagnostic test results including gastric emptying studies, upper endoscopy ruling out obstruction, CT scans Gastroenterologist consultation notes confirming gastroparesis diagnosis Ongoing treatment records showing persistent symptoms and quality of life impacts Documentation of work absences, disability claims, or lifestyle modifications necessitated by symptoms Certain factors may disqualify or weaken potential claims, making early case evaluation